1684-1182

Journal of Microbiology Immunology and Infection

Elsevier

View prefix report (10.1016)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 2743 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact2743 DOIs
2

Attach ORCID iDs across 1810 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact1810 DOIs
3

Deposit reference lists for 686 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact686 DOIs

DOIs for this ISSN

Showing the top 5 of 2743 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Asymptomatic carrier state, acute respiratory disease, and p… (10.1016/j.jmii.2020.02.012)
Abstract ORCID
141.11 663
2 TH17 responses in cytokine storm of COVID-19: An emerging ta… (10.1016/j.jmii.2020.03.005)
Abstract ORCID
140.94 658
3 Are children less susceptible to COVID-19? (10.1016/j.jmii.2020.02.011)
Abstract ORCID
131.92 434
4 ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hy… (10.1016/j.jmii.2020.04.015)
Abstract ORCID
130.16 400
5 Treatment options for COVID-19: The reality and challenges (10.1016/j.jmii.2020.03.034)
Abstract ORCID
129.88 395
6 Co-infections among patients with COVID-19: The need for com… (10.1016/j.jmii.2020.05.013)
Abstract ORCID
129.22 383
7 Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infe… (10.1016/j.jmii.2018.04.005)
Abstract ORCID
124.00 301
8 Antimicrobial peptides as potential anti-biofilm agents agai… (10.1016/j.jmii.2016.12.005)
Abstract ORCID
121.89 273
9 Prolonged viral shedding in feces of pediatric patients with… (10.1016/j.jmii.2020.03.021)
Abstract ORCID
119.90 249
10 Laboratory diagnosis of leptospirosis: A challenge (10.1016/j.jmii.2013.03.001)
Abstract ORCID
118.27 231
11 Emerging threats from zoonotic coronaviruses-from SARS and M… (10.1016/j.jmii.2020.02.001)
Abstract ORCID
116.62 214
12 COVID-19 associated with pulmonary aspergillosis: A literatu… (10.1016/j.jmii.2020.09.004)
Abstract ORCID
115.69 205
13 Dengue hemorrhagic fever – A systemic literature review of c… (10.1016/j.jmii.2020.03.007)
Abstract ORCID
113.94 189
14 Performance of a multiplex PCR pneumonia panel for the ident… (10.1016/j.jmii.2019.10.009)
Abstract ORCID
113.12 182
15 Lemierre's syndrome: A forgotten and re-emerging infection (10.1016/j.jmii.2020.03.027)
Abstract ORCID
110.74 163
16 A review of immunomodulators in the Indian traditional healt… (10.1016/j.jmii.2011.09.030)
Abstract ORCID
109.23 152
17 Proteus mirabilis urinary tract infection and bacteremia: Ri… (10.1016/j.jmii.2011.11.007)
Abstract ORCID
106.68 135
18 Screening of traditional Chinese medicinal plants for quorum… (10.1016/j.jmii.2009.10.001)
Abstract ORCID
106.36 133
19 Guidelines for the diagnosis, treatment, prevention and cont… (10.1016/j.jmii.2023.01.017)
Abstract ORCID
105.36 127
20 A systematic review and meta-analysis of diagnostic accuracy… (10.1016/j.jmii.2014.06.009)
Abstract ORCID
104.85 124
21 Effectiveness of an ultraviolet-C disinfection system for re… (10.1016/j.jmii.2017.08.017)
Abstract ORCID
104.67 123
22 Clinical and epidemiological features of Chryseobacterium in… (10.1016/j.jmii.2012.08.007)
Abstract ORCID
103.96 119
23 Pneumocystis jiroveci pneumonia in immunocompromised patient… (10.1016/j.jmii.2012.08.024)
Abstract ORCID
103.96 119
24 Rise of community-onset urinary tract infection caused by ex… (10.1016/j.jmii.2013.05.006)
Abstract ORCID
102.07 109
25 Consensus Statement on the Adherence to Clinical and Laborat… (10.1016/s1684-1182(10)60070-9)
Abstract ORCID
100.64 102
26 Recommendations and guidelines for the treatment of pneumoni… (10.1016/j.jmii.2018.11.004)
Abstract ORCID
100.43 101
27 Anti-quorum sensing activity of flavonoid-rich fraction from… (10.1016/j.jmii.2014.03.012)
Abstract ORCID
100.00 99
28 Comparisons of clinical features and mortality of cryptococc… (10.1016/j.jmii.2010.08.011)
Abstract ORCID
99.78 98
29 Honey: A realistic antimicrobial for disorders of the skin (10.1016/j.jmii.2015.01.009)
Abstract ORCID
99.78 98
30 Risk of tuberculosis infection in anti-TNF-α biological ther… (10.1016/j.jmii.2013.03.005)
Abstract ORCID
99.34 96
31 Immunomodulation and signaling mechanism of Lactobacillus rh… (10.1016/j.jmii.2015.05.002)
Abstract ORCID
99.34 96
32 Early life exposure to antibiotics and the risk of childhood… (10.1016/j.jmii.2013.04.005)
Abstract ORCID
98.89 94
33 Epidemiology and clinical outcome of pyogenic liver abscess:… (10.1016/j.jmii.2014.08.028)
Abstract ORCID
98.89 94
34 Virulence factors of uropathogenic Escherichia coli of urina… (10.1016/j.jmii.2013.07.010)
Abstract ORCID
98.66 93
35 Complexity of β-lactamases among clinical Aeromonas isolates… (10.1016/j.jmii.2012.08.008)
Abstract ORCID
98.42 92
36 Effects of immunomodulatory supplementation with Lactobacill… (10.1016/j.jmii.2014.08.001)
Abstract ORCID
98.19 91
37 Sphingomonas paucimobilis Bacteremia in Humans: 16 Case Repo… (10.1016/s1684-1182(10)60005-9)
Abstract ORCID
98.19 91
38 The sensor kinase BfmS mediates virulence in Acinetobacter b… (10.1016/j.jmii.2012.12.004)
Abstract ORCID
97.95 90
39 Interrupting COVID-19 transmission by implementing enhanced… (10.1016/j.jmii.2020.03.011)
Abstract ORCID
97.95 90
40 Causes, clinical symptoms, and outcomes of infectious diseas… (10.1016/j.jmii.2011.01.027)
Abstract ORCID
97.71 89
41 Clinical and epidemiologic features of Coxsackievirus A6 inf… (10.1016/j.jmii.2011.01.031)
Abstract ORCID
97.22 87
42 Subgingival microbiota in individuals with severe chronic pe… (10.1016/j.jmii.2016.04.007)
Abstract ORCID
96.72 85
43 Guidelines on Blood Cultures (10.1016/s1684-1182(10)60054-0)
Abstract ORCID
95.95 82
44 Clinical application of probiotics in the treatment of Helic… (10.1016/j.jmii.2013.03.010)
Abstract ORCID
95.69 81
45 Mycoplasma pneumoniae in pediatric patients: Do macrolide-re… (10.1016/j.jmii.2018.09.009)
Abstract ORCID
95.69 81
46 Recommendations for protecting against and mitigating the CO… (10.1016/j.jmii.2020.04.003)
Abstract ORCID
95.69 81
47 Staphylococcus lugdunensis Infective Endocarditis: A Literat… (10.1016/s1684-1182(10)60074-6)
Abstract ORCID
95.69 81
48 Characterization of an antimicrobial substance produced by L… (10.1016/j.jmii.2017.08.003)
Abstract ORCID
95.15 79
49 Clinical Outcome of Mycobacterium abscessus Infection and An… (10.1016/s1684-1182(10)60063-1)
Abstract ORCID
94.88 78
50 COVID-19 in long-term care facilities: An upcoming threat th… (10.1016/j.jmii.2020.04.008)
Abstract ORCID
94.60 77